Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Search
evaxion
-
search results
If you're not happy with the results, please do another search
BioStock met industry leaders at LSX
10 October, 2024
Rights issue takes Expres2ion breast cancer vaccine to phase I
14 June, 2024
WntResearch’s new CEO comments on his first month in the position
27 March, 2024
Evaxion partners with MSD for vaccine development
28 February, 2024
Evaxion to develop novel precision cancer vaccine concept
31 January, 2024
Can AI help solve cancer? – Evaxion Biotech talks AI, cancer...
22 December, 2023
Evaxion unveils refined business strategy
21 December, 2023
Evaxion establishes two Big Pharma partnerships
26 September, 2023
AI as a tool for drug development
21 September, 2023
Evaxion reaches key milestones during summer
24 August, 2023
Evaxion unveils genetic adjuvant technology to boost vaccines
7 June, 2023
AACR puts spotlight on personalised cancer vaccines
9 May, 2023
Evaxion to sharpen focus and launch new platform
3 April, 2023
ExpreS2ion’s CEO on current development and the rights issue
29 March, 2023
AI opens up opportunities in healthcare
9 March, 2023
Evaxion and Pantherna reach preclinical proof-of-concept
21 February, 2023
Evaxion receives Fast Track for cancer vaccine candidate
24 January, 2023
Evaxion receives phase IIb go-ahead from FDA
16 January, 2023
Evaxion and ExpreS²ion to collaborate on CMV vaccine
9 December, 2022
Watch the BioStock Life Science Fall Summit!
8 December, 2022
Can Nordic companies extend the life of Keytruda?
1 December, 2022
Evaxion comments on new strategic focus
16 November, 2022
Evaxion brings in Per Norlén as CEO
21 October, 2022
Evaxion enrols first patient in phase IIb melanoma study
3 October, 2022
Evaxion receives NIH grant for gonorrhoea vaccine
14 September, 2022
BioStock Life Science Fall Summit 2022
16 August, 2022
Evaxion Biotech expands its programme with a new indication
8 July, 2022
Evaxion Biotech Secures Equity Financing of up to 40 MUSD
10 June, 2022
Watch day 2 of the BioStock Life Science Spring Summit
9 June, 2022
The BioStock Life Science Spring Summit starts now
8 June, 2022
Evaxion Biotech shows strong clinical momentum in Q1
16 May, 2022
Cancer vaccines – a new frontier in immuno-oncology
7 April, 2022
BioStock Life Science Spring Summit, June 8-9, 2022
26 March, 2022
Evaxion completes EVX-02 clinical trial recruitment
15 March, 2022
Evaxion Biotech publishes EVX-01 data in scientific journal OncoImmunology
9 February, 2022
Evaxion Biotech gets a go-ahead for phase IIb with EVX-01
24 January, 2022
Capital injection sets Evaxion Biotech up for phase IIb trials
25 November, 2021
Evaxion Biotech to test EVX-01 in collaboration with Merck & Co.
29 October, 2021
Evaxion Biotech awarded by Frost & Sullivan for its AI platform
18 October, 2021
Evaxion Biotech leverages AI to fight cancer and infectious diseases
24 September, 2021
